Friedreich ataxia (FA) associated with diabetes mellitus type 1 and hyperthrophic cardiomyopathy

Bosnian Journal of Basic Medical Sciences

Volumn 9, Issue 2, 2009, Pages 107-110

  Gucev, Zoran ^a   Tasic, Velibor ^a   Jancevska, Aleksandra ^a   Popjordanova, Nada ^a   Koceva, Svetlana ^a   Kuturec, Marija ^a   Sabolic, Vesna ^a  

^a SS CYRIL AND METHODIUS UNIVERSITY   (Macedonia)

Author keywords

Diabetes mellitus type 1; Friedreich ataxia; Hyperthrophic cardiomyopathy; Siblings

Indexed keywords

FRATAXIN; IRON BINDING PROTEIN;

ADOLESCENT; ARTICLE; CASE REPORT; FEMALE; FRIEDREICH ATAXIA; GENETICS; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; INSULIN DEPENDENT DIABETES MELLITUS; TRINUCLEOTIDE REPEAT;

ADOLESCENT; CARDIOMYOPATHY, HYPERTROPHIC; DIABETES MELLITUS, TYPE 1; FEMALE; FRIEDREICH ATAXIA; HUMANS; IRON-BINDING PROTEINS; TRINUCLEOTIDE REPEATS;

EID: 67649411838     PISSN: 15128601     EISSN: None     Source Type: Journal    
DOI: 10.17305/bjbms.2009.2828     Document Type: Article

References (35)

1. Melo M., Fagulha A., Barros L., Guimarães J., Carrilho F., Carvalheiro M. Friedreich ataxia and diabetes mellitus--family study. Acta .Med. Port. 2005;18(6):479-483.
2. Legros B., Mantu M.. Friedreich ataxia: recent developments and prospects for treatment. Rev. Med. Brux. 1999; 20 (2): 73-79.
3. Dalatycki M.B., Knight M., Koening M., Cossee M., Williamson R., Forrest S.M. G130V, a common FRDA point mutation, appears to have arisen from a common founder. Hum. Genet. 1999; 105: 343-346.
4. Al-Mahdawi S., Pinto R.M., Varshney D., Lawrence L., Lowre M.B., Hughes S., Webster Z., Blake J., Cooper J.M., King R., Pook M.A. GAA repeat expansion mutation mouse models of Friedreich ataxia exhibit oxidative stress leading to progressive neuronal and cardiac pathology. Genomics 2006; 88: 580-590.
5. Pandolfo M. Friedreich's ataxia: clinical aspects and pathogenesis. Semin. Neurol. 1999;19(3):311-321.
6. De Castro M.,García-Planells J.,Monrós E.,Cañizares J.,Vázquez-Manrique R.,Vílchez J.J.,Urtasun M.,Lucas M.,Navarro G.,Izquierdo G.,Moltó M.D.,Palau F.. Genotype and phenotype analysis of Friedreich's ataxia compound heterozygous patients. Hum Genet 2000; 106 :86-92.
7. Koening M. Friedreich's ataxia. In: Rubinsztein D.C., Hayden M.R. (eds). Analysis of Triplet Repeat Disorders. Oxford: BIOS Sci. Pub. 1998: 219-238.
8. Hirayama K., Takayanagi T., Nakamura R., Yanagisawa N., Hattori T., Kita K., Yanagimoto S., Fujita M., Nagaoka M., Satomura Y., Sobue I., Iizuka R., Toyokura Y., Satoyoshi E. Spinocerebellar degenerations in Japan: a nationwide epidemiological and clinical study. Acta Neurol. Scand. 1994; 89 (suppl. 153): 1-22.
9. Dean G., Chamberlain S., Middleton L. Friedeich's ataxia in Kathikas-Arodhes, Cyprus. (Letter) Lancet II 1988: 587.
10. Barbeu A. Friedreich's ataxia 1978: an overview. Canad. J. Neurol. Sci. 1978; 5: 161-165.
11. Romeo G., Mennozi P., Ferlini A., Fadda S., Di Donato S., Uzel G., Luzzi B., Capodaglio L., Filla A., Campanella G. Incidence of Friedreich ataxia in Italy estimated from consanguineous marriages. Am. J. Hum. Genet. 1983; 35: 523-529.
12. Juvonen V., Kulmala S.M., Ignatius J., Penttinen M., Savontaus M.L. Dissecting the epidemiology of a trinucleotide repeat disease- example of FRDA in Finland. Hum. Genet. 2002; 110: 36-40.
13. Lodi R., Cooper J.M., Bradley J.L., Manners D., Styles P., Taylor D.J., Schapira A.H.V. Defi cit of in vivo mitochondrial ATP production in patients with Friedreich ataxia. Proc. Nat. Acad. Sci. 1999; 96: 11492-11495.
14. Filla A., De Michele G., Cavalcanti F., Pianese L., Monticelli A., Campanella G., Cocozza S. The relationship between trinucleotide (GAA) repeat length and clinical features in Friedreich ataxia. Am. J. Hum. Genet. 1996; 59: 554-560.
15. Isnard R., Kalotka H., Durr A., Cossee M., Schmitt M., Pousset F., Th omas D., Brice A., Koenig M., Komajda M. Correlation between left ventricular hypertrophy and GAA trinucleotide repeat length in Friedreich's ataxia. Circulation 1997; 95: 2247-2249.
16. Monros E., Smeyers P., Ramos M.A., Prieto F., Palau F. Prenatal diagnosis of Friedreich ataxia: improved accuracy by using new genetic flanking markers. Prenatal. Diag. 1995; 15: 551-554.
17. Durr A., Cossee M., Agid Y., Campuzano V., Mignard C., Penet C., Mandel J.L., Brice A., Koenig M. Clinical and genetic abnormalities in patients with Friedreich's ataxia. New Eng. J. Med. 1996; 335: 1169-1175.
18. Gottesfeld J.M. Small molecules aff ecting transcription in Friedreich ataxia. Pharmacol. Ther. 2007;116(2):236-248.
19. Palau F. Friedreich's ataxia and frataxin: molecular genetics, evolution and pathogenesis (Review). Int. J. Mol. Med. 2001; 7(6):581-589.
20. Podolsky S., Sheremata M.D. Insulin-dependent diabetes mellitus and Friedreich's ataxia in siblings. Metabolism 1970; 19(8): 555-561.
21. Greco A.V., Ghirlanda G., Cocci A., Fedeli G., Rebuzzi A.G.. The association of diabetic disease in members of the same family. Minerva Med 1975; 66(34): 1608-1617.
22. Bird T.D., Turner J.L., Sumi S.M., Bierman E.L. Abnormal function of endocrine pancreas and anterior pituitary in Friedreich's ataxia. Studies in a family. Ann. Intern. Med. 1978; 88(4):478-481.
23. Schoenle E.J., Boltshauser E.J., Baekkeskov S., Landin Olsson M., Torresani T., von Felten A. Preclinical and manifest diabetes mellitus in young patients with Friedreich's ataxia: no evidence of immune process behind the islet cell destruction. Diabetologia 1989; 32(6):378-381.
24. Ristow M. Neurodegenerative disorders associatedwith diabetes mellitus. J. Mol. Med. 2004; 82(8): 510-529.
25. Hewer R.L. Study of fatal cases of Friedreich's ataxia. Brit. Med. J. 1968; 3: 649-652.
26. 25/frataxin gene is associated with insulin resistance in humans. Diabetes 2000; 49: 1604-1607.
27. Fantus I.G., Seni M.H., Andermann E. Evidence for abnormal regulation of insulin receptors in Friedreich's ataxia. J. Clin. Endocrinol. Metab. 1993;76(1):60-63.
28. Joffe B. II., Segal R., Cooper W. Evolution of diabetes mellitus in a case of Friedreich's ataxia. Journal of Neurology, Neurosurgery, and Psychiatry. 1973, 36, 484-485.
29. Shapcott D., Melancon S., Butterworth R.F., Khoury K., Collu R., Breton G., Geoff roy G., Lemieux B., Barbeau A. Glucose and insulin metabolism in Friedreich's ataxia. Can. J. Neurol. Sci. 1976; 3(4):361-364. (Pubitemid 8067192)
30. Bertoni P.D., Canziani R., Cozzi G., Arancio F., Marforio S. Cardiac involvement in Friedreich's heredo-ataxia. G. Ital. Cardiol. 1986;16(1):22-29.
31. Alboliras E.T., Shub C., Gomez M.R., Edwards W.D., Hagler D.J., Reeder G.S., Seward J.B., Tajik A.J. Spectrum of cardiac involvement in Friedreich's ataxia: clinical, electrocardiographic and echocardiographic observations. Am. J. Cardiol. 1986; 58(6):518-524.
32. Günal N.,Saraçlar M.,Ozkutlu S.,Senocak F.,Topaloǧlu H.,Karaaslan S.. Heart disease in Friedreich's ataxia: a clinical and echocardiographic study. Acta Paediatr. Jpn. 1996; 38(4):308-311.
33. Boesch S., Sturm B., Hering S., Goldenberg H., Poewe W., Scheiber-Mojdehkar B. Friedreich's ataxia: clinical pilot trial with recombinant human erythropoietin. Ann. Neurol. 2007; 62:521-524.
34. Jauslin M.L., Wirth T., Meier T., Schoumacher F. A cellular model for Friedreich ataxia reveals small molecule gluthatione peroxidase mimetics as novel treatment strategy. Hum. Molec. Genet. 2002; 110: 36-40.
35. Cooper J.M., Korlipara L.V., Hart P.E., Bradley J.L., Schapira A.H. Coenzyme Q10 and vitamin E defi ciency in Friedreich's ataxia: predictor of effi cacy of vitamin E and coenzyme Q10 therapy. Eur. J. Neurol. 2008;15(12):1371-1379.